Evidence map›Paper›PMID 28701359›Full record

ArticleAmerican journal of physiology. Cell physiology2017

oxLDL induces endothelial cell proliferation via Rho/ROCK/Akt/p27

Chongxu Zhang, Crystal Adamos, Myung-Jin Oh, Jugajyoti Baruah, Manuela A A Ayee, Dolly Mehta, Kishore K Wary, Irena Levitan

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Emerging Anti-Atherosclerotic Therapies.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Epigenetics of chronic inflammatory diseases.Journal of inflammation research · 2019
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chongxu ZhangDivision of Pulmonary and Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and.
Crystal AdamosDivision of Pulmonary and Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and.
Myung-Jin OhDivision of Pulmonary and Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and.
Jugajyoti BaruahDepartment of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
Manuela A A AyeeDivision of Pulmonary and Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and.
Dolly MehtaDepartment of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
Kishore K WaryDepartment of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
Irena LevitanDivision of Pulmonary and Critical Care, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and levitan@uic.edu.
University of Illinois Chicago · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Trpm2 Regulation of Phagocyte Bactericidal Activity and Resolution of Lung InjuryP01HL077806 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2005 to 2019
$27.0M
RESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M
Regulation of Wnt Signaling by PAP2b During AngiogenesisR01HL079356 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WARY, KISHORE K · 2006 to 2016
$3.0M
Mechanisms of endothelial regeneration and resolution of lung vascular injuryR01HL137169 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2017 to 2020
$2.1M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL077806NHLBI NIH HHS R01 HL079356NHLBI NIH HHS R01 HL137169NHLBI NIH HHS T32 HL007605
6 · The paper itself

Abstract

Oxidized modifications of LDL (oxLDL) play a key role in the development of endothelial dysfunction and atherosclerosis. However, the underlying mechanisms of oxLDL-mediated cellular behavior are not completely understood. Here, we compared the effects of two major types of oxLDL, copper-oxidized LDL (Cu

Indexed as

Cell ProliferationCells, CulturedCholesterolCyclin-Dependent Kinase Inhibitor p27Endothelial CellsGene Expression Regulation, EnzymologicHumansLipoproteins, LDLOncogene Protein v-aktrho-Associated KinasesSignal TransductionCholesterolCyclin-Dependent Kinase Inhibitor p27Lipoproteins, LDLOncogene Protein v-aktoxidized low density lipoproteinrho-Associated Kinasesoxidized modifications of low-density lipoproteinsRho kinase

Identifiers

PMID28701359
PMCPMC5625097
OpenAlexW2734354365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.